Reports Q4 revenue $8.22B, consensus $7.87B. "The fourth quarter completes another strong year of operating and financial performance," said Joseph Zubretsky, President and Chief Executive Officer. "We are very pleased with our business performance during the year, as well as the progress we made in 2022 on our growth strategy, which has created a solid and growing financial profile as we head into 2023."
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MOH:
- Molina Healthcare price target lowered to $375 from $400 at Barclays
- Molina Healthcare to double California revenue with Medi-Cal contracts in 2024
- Molina Healthcare to record $200M impairment charge in Q4 on leased space
- Molina Healthcare upgraded to Neutral at BofA on ‘high confidence’ in EPS growth
- Molina Healthcare upgraded to Neutral from Underperform at BofA